Microsoft has introduced its cancer care agent orchestrator to the Azure AI Foundry Agent Catalog, expanding its suite of tools for building enterprise-ready AI applications. Designed to coordinate multiple AI agents, the orchestrator supports complex healthcare tasks by integrating with systems like Microsoft Teams and Word, and handling diverse data types including EHRs, DICOM files, genomics, and pathology images.

Focused on oncology, the orchestrator features customizable, open-source agents that enable developers and researchers to create tailored workflows. These agents automate critical functions such as generating patient timelines, identifying cancer stages, and streamlining documentation. Microsoft claims this system can reduce administrative burden, accelerate insights, and enhance clinician support through modular, multimodal AI collaboration.

Each agent is powered by advanced models from Azure AI Foundry, blending general-purpose reasoning with health-specific capabilities. The orchestrator ensures transparency by grounding AI-generated outputs in clinical data, a vital feature for adoption in high-stakes environments.

Organizations including Stanford Medicine, Johns Hopkins, and Mass General Brigham are exploring the orchestrator’s real-world use. Stanford's CIO highlighted its potential to improve tumor board processes by surfacing complex data like trial eligibility and treatment guidelines, aiming to become the first production-level generative AI tool in clinical cancer care.

This launch aligns with Microsoft’s broader AI initiatives, including the addition of xAI’s Grok 3 model to Azure and ongoing partnerships like Blue Shield of California’s Experience Cube and Fujitsu’s HL7 FHIR-based health data platform—all aimed at advancing AI-driven, personalized healthcare.